Reardon Andrew sold LGND
August 10, 2025 · Form 4 insider transaction
Reardon Andrew sold 1,325 shares of Ligand Pharmaceuticals Incorporated at $150.06 per share, a transaction worth $198.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,325
Price
$150.06
Total value
$198.8K
InsiderReardon Andrew
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateAugust 10, 2025
Filing dateAugust 12, 2025
Shares owned after30,811
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.